Manufacturer record
Pushkar Pharma: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
12 batches manufactured by Pushkar Pharma (Himachal Pradesh) were declared Not of Standard Quality between April 2020 and June 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: CLT-214A, Clotrimazole Ear Drops (exp Jul 2026). CDL Kolkata (CDSCO lab) found it not of standard quality: Assay of Clotrimazole. Listed in the June 2025 alert.
Records by type
12 records linked to Pushkar Pharma in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Clotrimazole Ear Drops | Batch CLT-214AMfg Aug 2024 · Exp Jul 2026 | Assay of ClotrimazoleAssay | CDL KolkataCDSCO lab | Jun 2025 |
| Amoxycillin and Potassium Clavulanate Injection IP | Batch ACP-738AMfg Sep 2023 · Exp Aug 2025 | Assay of Potassium Clavulanate equivalent to Clavulanic AcidAssay | CDL KolkataCDSCO lab | Jun 2025 |
| Phenytoin Sodium Injection USP | Batch PTS-225AMfg May 2024 · Exp Apr 2026 | Alcohol Content and Propylene Glycol contentOther | CDL KolkataCDSCO lab | Feb 2025 |
| Oxytocin Injection I.P. 5 IU/1 ml | Batch OTC-382AMfg Apr 2023 · Exp Mar 2025 | Description, Particulate matter & Assay of OxytocinAssay | CDL KolkataCDSCO lab | Sep 2024 |
| Enrofloxacin Injection IP (Vet.) | Batch VENF-250AMfg Jan 2022 · Exp Dec 2023 | pHpH | RDTL ChandigarhState lab | Apr 2023 |
| MIDAZOLAM INJECTION IP | Batch MDM-155AMfg Mar 2022 · Exp Feb 2024 | pH and AssayAssay | RDTL ChandigarhState lab | Oct 2022 |
| Gentamicin Injection I.P. (Vet) ? 30 ml | Batch VGTA-108AMfg Dec 2021 · Exp Nov 2023 | Description and Particulate MatterDescription | CDL KolkataCDSCO lab | Aug 2022 |
| PHENYTOIN SODIUM INJECTION USP | Batch PTS-155AMfg Oct 2021 · Exp Sep 2023 | pHpH | RDTL ChandigarhCDSCO lab | Feb 2022 |
| OXYTOCIN INJECTION IP | Batch OTC-233AMfg Feb 2021 · Exp Jul 2022 | Assay of Oxytocin ActivityAssay | RDTL ChandigarhState lab | Sep 2021 |
| Budesonide Nebuliser Suspension BP (0.5 mg/2 ml) (BUDELIFE RESPULES | Batch OTC-256AMfg Apr 2021 · Exp Sep 2022 | Assay of BudesonideAssay | RDTL ChandigarhState lab | Sep 2021 |
| OXYTOCIN INJECTION I.P. | Batch OTC-232AMfg Feb 2021 · Exp Jul 2022 | Assay of Oxytocin ActivityAssay | RDTL ChandigarhState lab | Aug 2021 |
| Lignocaine With Adrenaline Injection IP | Batch LAN-113AMfg Jul 2019 · Exp Dec 2020 | Assay of Adrenaline BitartrateAssay | RDTL ChandigarhCDSCO lab | Apr 2020 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.